Arkolith/Insider Trading/ELDN/Form 4

Biotechnology Value Fund II LP

InsiderEledon Pharmaceuticals, Inc. (ELDN) · full profile →Form 4 · filed Oct 31, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 29, 2024Buy(P)2.2M$3.65$8.1M7.4M
Oct 29, 2024Buy(P)2.1M$3.65$7.7M6.2M
Oct 29, 2024Buy(P)440K$3.65$1.6M839K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-24-002408) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML